Analysis of Vaccine Reactions After Booster Doses Among Pregnant, Lactating Individuals

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30495?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The findings of this study with 17,000 participants suggest that COVID-19 boosters or third doses were well tolerated by individuals who were pregnant and lactating. Data on COVID-19 vaccine boosters are particularly important as vaccine uptake during pregnancy is lagging, and strategies to reduce hesitancy, increase acceptance, and help guide discussions between pregnant and lactating persons and maternal care professionals are needed.

Authors: Alisa Kachikis, M.D., M.S., of the University of Washington in Seattle, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.30495)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.